JHI takes the reins of Mubadala deal
by ArabianBusiness.com staff writer on Saturday, 23 August 2008
US consultants Johns Hopkins Medicine International is to run the United Arab Emirates’ first molecular imaging centre, Medical Times has learnt.
The group will oversee the centre alongside its current role as operations manager of the government-owned Tawam Hospital, Al Ain.
The molecular centre is the result of tie-up between Mubadala Development and Siemens Medical Solutions. The facility is expected to provide oncology, cardiology and neurology services, and will include a PET/CT diagnostic system and a cyclotron radioisotope delivery system.
The PET/CT system is thought to be the first operational unit in the country.
Dr Ahmed Al Mazrouei, chairman of Health Authority Abu Dhabi, described the news as an excellent example of how commercial expertise can be used to fast-track the public sector's healthcare facilities.
READERS' COMMENTS
MORE FROM ARABIANBUSINESS.COM
TOP IN MIDDLE EAST HEALTHCARE
TOP MIDDLE EAST BUSINESS STORIES
ALSO IN MIDDLE EAST HEALTHCARE
LATEST MIDDLE EAST BUSINESS NEWS
- Education: Mubadala completes $1bn financing for uni project
- Banking & Finance: Deal sought on Dubai World, Nakheel debts
- Banking & Finance: Arab youth SMEs turn to family finance
- Banking & Finance: Dubai raises further $5bn in bond sale
- Transportation: Shipping slump stops Bahrain's new port signing main liner
SHARE PRICE CHECK
RELATED STORIES
Abu Dhabi Health Authority
- Transplant patients suffer location-lotto
2 Dec '08 | News - HAAD backs malpractice export policy
20 Oct '08 | News - Abu Dhabi seeks private investors in healthcare
14 Oct '08 | News
Johns Hopkins Medicine International
- Teutonic trading
14 Dec '08 | Features




